Physician profile
David Weinstein
NPI 1093765927
$7,872.66
in general payments reported to CMS, 2019-2025
42 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $624 · 2021: $1,114 · 2022: $796 · 2023: $902 · 2024: $1,409 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,866 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,866.21 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,197.88 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $954.63 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Abbvie INC. | $731.12 | 2019-2025 | Lupron Depot, Botox |
| Endo Pharmaceuticals INC. | $554.76 | 2019-2024 | Xiaflex, Aveed, Edex |
| Pfizer INC. | $462.63 | 2019-2025 | |
| Neotract INC. | $433.74 | 2019-2020 | |
| Rochester Medical Corporation | $427.52 | 2021-2022 | |
| Endo USA, INC. | $299.51 | 2024-2025 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $229.62 | 2024-2025 | Prolaris |
| Ferring Pharmaceuticals INC. | $220.38 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $194.86 | 2021-2025 | |
| Boston Scientific Corporation | $190.43 | 2019-2025 | Rezum Generator, Ams 700 |
| Procept Biorobotics Corporation | $186.41 | 2023-2025 | Aquabeam Robotic System |
| Laborie Medical Technologies Corp. | $185.66 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Blue Earth Diagnostics | $170.53 | 2021-2025 | Posluma |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $146.37 | 2023 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $139.89 | 2019-2022 | |
| Allergan, INC. | $120.12 | 2019-2022 | |
| Tolmar, INC. | $110.19 | 2023-2025 | Eligard, Jatenzo |
| Dendreon Pharmaceuticals LLC | $105.89 | 2019-2025 | Provenge |
| Olympus America INC. | $83.44 | 2021-2025 | Olympus, Itind System, Soltive |
| Novartis Pharmaceuticals Corporation | $80.10 | 2025 | |
| Becton, Dickinson and Company | $77.76 | 2024-2025 | Bard Urinary Drainage Bag |
| C. R. Bard, INC. & Subsidiaries | $60.68 | 2019-2025 | Bard Urinary Drainage Bag |
| Verity Pharmaceuticals INC. | $56.08 | 2022-2024 | Trelstar |
| Myovant Sciences INC. | $55.57 | 2021 | |
| Coloplast Corp | $48.27 | 2019-2022 | |
| Medical Device Business Services, INC. | $47.01 | 2024 | Healix Knotless Peek |
| Immunitybio, INC. | $44.05 | 2024-2025 | |
| Axonics, INC. | $35.73 | 2022 | |
| Ambu INC. | $26.48 | 2024 | |
| Accord Healthcare, INC. | $24.42 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $24.06 | 2022 | |
| Progenics Pharmaceuticals, INC. | $23.92 | 2024 | |
| Antares Pharma, INC. | $23.54 | 2024 | Xyosted |
| Calyxo, INC. | $23.00 | 2025 | Cvac Aspiration System |
| Urovant Sciences INC | $22.26 | 2022 | |
| Roche Diagnostics Corporation | $17.52 | 2020 | |
| Valencia Technologies Corporation | $14.06 | 2025 | Ecoin Device Kit |
| Bard Access Systems, INC. | $14.03 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.